Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?

STUDY DESIGN: Single center retrospective cohort analysis. PURPOSE: The goal was to evaluate the influence of varying amount of recombinant human bone morphogenetic protein 2 (rhBMP-2) per level on fusion rates and complications in posterolateral spinal fusions. OVERVIEW OF LITERATURE: rhBMP-2 has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Martin Franz, Jones, Clifford Barry, Sietsema, Debra Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Spine Surgery 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917763/
https://www.ncbi.nlm.nih.gov/pubmed/27340524
http://dx.doi.org/10.4184/asj.2016.10.3.457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917763/
https://www.ncbi.nlm.nih.gov/pubmed/27340524
http://dx.doi.org/10.4184/asj.2016.10.3.457

Ejemplares similares